CRNX:NASDAQ
Crinetics Pharmaceuticals Inc
$84.95
0.00%
(0.00) 1D
Aug 31, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRNX...
Mkt. cap
9.01B
Avg. vol.
2.68M
Volume
0.00
52-wk high
$85.01
52-wk low
$31.00
EPS
-$5.05
Beta
0.12
Shares outstanding
106.06M
No. of employees
594
Mkt. cap
9.01B
Avg. vol.
2.68M
Volume
0.00
52-wk high
$85.01
52-wk low
$31.00
EPS
-$5.05
Beta
0.12
Shares outstanding
106.06M
No. of employees
594
News stories
From web sources and news partners
Quiver Quantitative
·
2 days ago
Vertex shares fall as investors digest Crinetics acquisition and related financing plans
https://www.dars.gov.et/
·
6 days ago
Crinetics Pharmaceuticals (CRNX) Holds Steady at $84.95 as Shares Consolidate Within Established Range - Blue Chip Entry Points
Profile
Crinetics Pharmaceuticals was a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
In July 2026, Vertex Pharmaceuticals agreed to acquire the company for $10 billion. The acquisition closed in September of 2026. Wikipedia
About Crinetics Pharmaceuticals Inc